『文獻精讀』
掌握最新學術(shù)動態(tài)
擴展麻醉專業(yè)知識
進行科研文章撰寫
歡 迎 關 注 Luffy麻醉頻道
超聲引導下豎脊肌平面阻滯用于腹腔鏡肝切除術(shù)的術(shù)后鎮(zhèn)痛
一項前瞻性、隨機對照、患者與觀察者雙盲研究
翻譯:苗 丹尼
01
背景
BACKGROUND Erector spinae plane block (ESPB) has been reported to manage postoperative pain effectively after various types of surgery. However, there has been a lack of study on the effect of ESPB after liver resection.
背景:豎脊肌平面阻滯(ESPB)已被報道可有效應用于各種手術(shù)后的術(shù)后疼痛。然而,關于肝切除術(shù)后ESPB效果的研究一直是缺乏報道。
02
方法
OBJECTIVES To investigate the analgesic effects of ESPB on pain control after laparoscopic liver resection compared with conventional pain management.
目的:探討腹腔鏡下肝切除術(shù)后,與常規(guī)疼痛管理方法比較,使用豎脊肌平面阻滯控制疼痛的效果。
DESIGN Prospective, randomised controlled study.
設計:前瞻性、隨機對照研究。
SETTINGA single tertiary care centre from February 2019 to February 2020.
試驗地點和時間:三級醫(yī)療中心,從2019年2月至2020年2月。
PATIENTS A total of 70 patients scheduled to undergo laparoscopic liver resection.
病人:共有70例患者計劃行腹腔鏡肝切除術(shù)。
INTERVENTIONS In the control group (n=35), no procedure was performed. In the ESPB group (n=35), ESPB was performed after induction of general anaesthesia. A total of 40ml of ropivacaine 0.5% was injected at the T9 level bilaterally. After surgery, intravenous fentanyl patient-controlled analgesia was initiated. Fentanyl and hydromorphone were administered as rescue analgesics.
干預措施:對照組(n = 35)未進行疼痛干預。
ESPB組(n = 35)在全麻誘導后進行ESPB。共40ml 0.5%羅哌卡因在T9水平雙側(cè)注射。
手術(shù)后,開始使用芬太尼靜脈自控鎮(zhèn)痛。給予芬太尼和氫嗎啡酮作為補救性鎮(zhèn)痛藥。
MAIN OUTCOME MEASURES The primary outcome was the cumulative postoperative opioid consumption at 24h (morphine equivalent). The secondary outcomes were rescue opioid (fentanyl) dose in the postanaesthesia care unit (PACU) and pain severity at 1, 6, 12, 24, 48 and 72h, assessed using a numerical rating scale (NRS) score.
主要結(jié)局指標:
主要結(jié)局指標是術(shù)后24小時阿片類藥物累計消耗量(嗎啡等效劑量)。
次要結(jié)局指標是麻醉后恢復室(PACU)的阿片類藥物(芬太尼)補救性使用劑量和1、6、12、24、48和72小時的疼痛嚴重程度,使用數(shù)字評分量表(NRS)進行評估。
Table&Figure
圖1流程圖
表1病人特征
表2術(shù)中和術(shù)后數(shù)據(jù)資料
圖2術(shù)后不同時間數(shù)字評分量表得分
03
結(jié)果
RESULTS The median [IQR] cumulative postoperative opioid consumption at 24h was 48.2 [17.1] mg in the control group and 45.5 [35.8] mg in the ESPB group (median difference, 4.2 mg, 95% CI, -4.2 to 13.3 mg, P=0.259). Conversely, rescue opioid in PACU was 5.3 [5.0] mg in the control group and 3.0 [1.5] mg in the ESPB group (median difference 2.5mg, 95% CI, 1.0 to 5.0 mg, P<0.001). There was no significant difference in NRS scores point between the groups at any time.
結(jié)果:對照組術(shù)后24小時阿片類藥物累計消耗量的中位數(shù)[四分位間距]為48.2 [17.1]mg, ESPB組為45.5 [35.8]mg(中位數(shù)差異,4.2 mg, 95% CI, -4.2—13.3 mg, P = 0.259)。
相反,PACU中阿片類藥物補救性使用劑量在對照組中為5.3 [5.0]mg,在ESPB組中為3.0 [1.5]mg(中位數(shù)差異為2.5mg, 95% CI, 1.0—5.0 mg, P<0.001)。
兩組在不同時間點的NRS評分無顯著性差異。
04
結(jié)論
CONCLUSION ESPB does not provide any measurable analgesic effect within 24h after laparoscopic liver resection.
結(jié)論:ESPB在腹腔鏡肝切除術(shù)后24h內(nèi)無明顯鎮(zhèn)痛作用。
05
文章來源
所屬分類:首頁 > SCI期刊 > 醫(yī)學
期刊名: EUROPEAN JOURNAL OF ANAESTHESIOLOGY
期刊名縮寫:EUR J ANAESTH
國際刊號:0265-0215
2020年影響因子/JCR分區(qū):4.500/Q3
出版國家或地區(qū):ENGLAND
出版周期:Monthly
出版年份:1984
年文章數(shù):74
是否OA開放訪問:No
官方網(wǎng)站:journals.cambridge.org/action/displayJournal?jid=EJA
學習筆記
專業(yè)英語
Hepat- 肝
Hepatic肝的
Hepatic artery 肝動脈
Hepatic cirrhosis 肝硬化
Hepatic failure 肝衰竭
Hepatitis肝炎
Hepatic carcinoma 肝癌
Hepatic encephalopathy 肝性腦病
-tectomy/ectomy 切除術(shù)
Hysterectomy 子宮切除術(shù)
Tonsillectomy 扁桃體切除術(shù)
Mastectomy 乳房切除術(shù)
Cholecystectomy 膽囊切除術(shù)
聯(lián)系客服